{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T23:21:46Z","timestamp":1787440906559,"version":"build-2736575974"},"reference-count":20,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ijantimicag.2026.107882","type":"journal-article","created":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T17:12:24Z","timestamp":1781457144000},"page":"107882","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Risk factors and outcome of extended-spectrum \u03b2-lactamase-producing Enterobacterales bacteraemia in high-risk neutropenic patients in haematology: A multicentre retrospective study"],"prefix":"10.1016","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8804-3715","authenticated-orcid":false,"given":"William","family":"Lars","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Gaborit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9596-662X","authenticated-orcid":false,"given":"Anne","family":"Coste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amandine","family":"Le Bourgeois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4932-2169","authenticated-orcid":false,"given":"Tony","family":"Marchand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ga\u00eblle","family":"Guillerm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lie","family":"Guillouzouic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrien","family":"Turban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudie","family":"Lamoureux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sch\u00e9h\u00e9razade","family":"Rezig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Boutoille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthieu","family":"Revest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9verine","family":"Ansart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4791-4219","authenticated-orcid":false,"given":"Jean-Philippe","family":"Talarmin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rapha\u00ebl","family":"Paret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2026.107882_bib0001","article-title":"Empirical and targeted antimicrobial therapy in patients with febrile neutropenia and haematological malignancy or after haematopoietic cell transplantation: recommendations from the 10th European Conference on Infections in Leukaemia","volume":"25","author":"Averbuch","year":"2025","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijantimicag.2026.107882_bib0002","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1093\/cid\/ciz319","article-title":"Inappropriate empirical antibiotic treatment in high-risk neutropenic patients with bacteremia in the era of multidrug resistance","volume":"70","author":"Martinez-Nadal","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.ijantimicag.2026.107882_bib0003","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s10096-013-1819-7","article-title":"Recent changes in bacteremia in patients with cancer: a systematic review of epidemiology and antibiotic resistance","volume":"32","author":"Montassier","year":"2013","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2026.107882_bib0004","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciae403","article-title":"Infectious Diseases Society of America 2024 guidance on the treatment of antimicrobial-resistant gram-negative infections","author":"Tamma","year":"2024","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2026.107882_bib0005","doi-asserted-by":"crossref","first-page":"e3842","DOI":"10.1093\/cid\/ciaa1479","article-title":"Association between minimum inhibitory concentration, beta-lactamase genes and mortality for patients treated with piperacillin\/tazobactam or meropenem from the MERINO study","volume":"73","author":"Henderson","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2026.107882_bib0006","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1001\/jama.2018.12163","article-title":"Effect of piperacillin-tazobactam vs meropenem on 30-day mortality for patients with E coli or Klebsiella pneumoniae bloodstream infection and ceftriaxone resistance: a randomized clinical trial","volume":"320","author":"Harris","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.ijantimicag.2026.107882_bib0007","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1093\/jac\/dkac135","article-title":"Resistance to empirical \u03b2-lactams recommended in febrile neutropenia guidelines in gram-negative bacilli bloodstream infections in Spain: a multicentre study","volume":"77","author":"Chumbita","year":"2022","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2026.107882_bib0008","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.ijantimicag.2018.12.003","article-title":"Associated factors and clinical outcomes of bloodstream infection due to extended-spectrum \u03b2-lactamase-producing Escherichia coli and Klebsiella pneumoniae during febrile neutropenia","volume":"53","author":"Ben-Chetrit","year":"2019","journal-title":"Int J Antimicrob Agents"},{"issue":"4","key":"10.1016\/j.ijantimicag.2026.107882_bib0009","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s00277-012-1631-y","article-title":"Escherichia coli and Klebsiella pneumoniae bacteremia in patients with neutropenic fever: factors associated with extended-spectrum \u03b2-lactamase production and its impact on outcome","volume":"92","author":"Kim","year":"2013","journal-title":"Ann Hematol"},{"issue":"6","key":"10.1016\/j.ijantimicag.2026.107882_bib0010","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1089\/mdr.2020.0033","article-title":"Epidemiology, risk factors, and clinical outcomes of bloodstream infection due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in hematologic malignancy: a retrospective study from Central South China","volume":"27","author":"Liang","year":"2021","journal-title":"Microb Drug Resist"},{"issue":"1","key":"10.1016\/j.ijantimicag.2026.107882_bib0011","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00277-011-1247-7","article-title":"Risk factors for infection and treatment outcome of extended-spectrum \u03b2-lactamase-producing Escherichia coli and Klebsiella pneumoniae bacteremia in patients with hematologic malignancy","volume":"91","author":"Kang","year":"2012","journal-title":"Ann Hematol"},{"key":"10.1016\/j.ijantimicag.2026.107882_bib0012","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1093\/jac\/dkac190","article-title":"Safety and risk of febrile recurrence after early antibiotic discontinuation in high-risk neutropenic patients with haematological malignancies: a multicentre observational study","volume":"77","author":"Paret","year":"2022","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2026.107882_bib0013","doi-asserted-by":"crossref","first-page":"e573","DOI":"10.1016\/S2352-3026(17)30211-9","article-title":"Optimisation of empirical antimicrobial therapy in patients with haematological malignancies and febrile neutropenia (How Long study): an open-label, randomised, controlled phase 4 trial","volume":"4","author":"Aguilar-Guisado","year":"2017","journal-title":"Lancet Haematol"},{"issue":"7","key":"10.1016\/j.ijantimicag.2026.107882_bib0014","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.ajic.2015.02.030","article-title":"Risk factors for bloodstream infection caused by extended-spectrum \u03b2-lactamase-producing Escherichia coli and Klebsiella pneumoniae: a focus on antimicrobials including cefepime.Am","volume":"43","author":"Chopra","year":"2015","journal-title":"J Infect Control"},{"issue":"1","key":"10.1016\/j.ijantimicag.2026.107882_bib0015","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.cmi.2019.05.013","article-title":"Estimating the association between antibiotic exposure and colonization with extended-spectrum \u03b2-lactamase-producing gram-negative bacteria using machine learning methods: a multicentre, prospective cohort study","volume":"26","author":"Tacconelli","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2026.107882_bib0016","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ijid.2016.01.006","article-title":"Differences in characteristics between first and breakthrough neutropenic fever after chemotherapy in patients with hematologic disease","volume":"44","author":"Nam","year":"2016","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2026.107882_bib0017","first-page":"2287","article-title":"Risk factors for piperacillin\/tazobactam-resistant gram-negative infection in hematology\/oncology patients with febrile neutropenia","volume":"23","author":"Marini","year":"2015","journal-title":"Support Care Cancer"},{"issue":"1","key":"10.1016\/j.ijantimicag.2026.107882_bib0018","doi-asserted-by":"crossref","first-page":"1800897","DOI":"10.1080\/19490976.2020.1800897","article-title":"Impact and consequences of intensive chemotherapy on intestinal barrier and microbiota in acute myeloid leukemia: the role of mucosal strengthening","volume":"12","author":"Hueso","year":"2020","journal-title":"Gut Microbes"},{"issue":"7","key":"10.1016\/j.ijantimicag.2026.107882_bib0019","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1093\/cid\/cis580","article-title":"Intestinal domination and the risk of bacteremia in patients undergoing allogeneic hematopoietic stem cell transplantation","volume":"55","author":"Taur","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2026.107882_bib0020","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1017\/S0022172400021653","article-title":"Colonization resistance of the digestive tract in conventional and antibiotic-treated mice","volume":"69","author":"van der Waaij","year":"1971","journal-title":"J Hyg (Lond)"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092485792600169X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092485792600169X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T22:40:59Z","timestamp":1787438459000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092485792600169X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":20,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S092485792600169X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2026.107882","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk factors and outcome of extended-spectrum \u03b2-lactamase-producing Enterobacterales bacteraemia in high-risk neutropenic patients in haematology: A multicentre retrospective study","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2026.107882","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107882"}}